But foremost, the broad expression of MIC and ULBP molecules by tumor cell lines and human tumors in contrast to the corresponding non-malignant tissues has spawned most interest in harnessing the NKG2D/NKG2DL system for cancer immunotherapy (16–18). Here, KLRK1 is linked to neoplasm.